Cargando…
COVID-19 Vaccines in Patients With Chronic Liver Disease
The COVID-19 pandemic has caused mayhem globally since the beginning of 2020. Owing to the immune dysfunction inherent to cirrhosis and the poor general condition, patients with chronic liver disease (CLD) are at higher risk of mortality and morbidity due to COVID-19. Recently, a number of vaccines...
Autores principales: | Sharma, Anand, Patnaik, Itish, Kumar, Ashok, Gupta, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214314/ https://www.ncbi.nlm.nih.gov/pubmed/34177192 http://dx.doi.org/10.1016/j.jceh.2021.06.013 |
Ejemplares similares
-
Letter to the editor in response to COVID-19 presenting as acute pancreatitis
por: Gupta, Rohit, et al.
Publicado: (2020) -
Hyperlipasemia in COVID-19: Statistical Significance vs Clinical Relevance
por: Rathi, Sahaj, et al.
Publicado: (2020) -
Therapeutic plasma exchange in acute fatty liver of pregnancy: a case report and literature review
por: Kumar, Ajay, et al.
Publicado: (2021) -
Coronavirus disease 2019 and the pancreas
por: Samanta, Jayanta, et al.
Publicado: (2020) -
Yoga for COVID – 19
por: Patel, Nupur B., et al.
Publicado: (2021)